
Is the century-long search for a weight loss drug over?
If You're Listening
00:00
Introduction
This chapter explores the sudden increase in value of Novo Nordisk, Europe's most valuable company, and the role of their drug semaglutide in treating type 2 diabetes and aiding weight loss, with endorsements from celebrities like Elon Musk and Amy Schumer.
Transcript
Play full episode